New research findings on the SAVI® breast
brachytherapy applicator showed favorable results for treatment of early-stage breast cancer, according to a scientific poster at the 2012 Breast Cancer Symposium. View poster

Examining initial and longer-term effects among a group of 904 patients at 12 centers around the U.S., researchers found low rates of toxicities – including seroma, fat necrosis and telangiectasia – among patients treated with strut-based brachytherapy.